Dihydropyrazolo[3,4-d]thieno-[2,3-B]pyridinone inhibitors of B7-1
申请人:Wyeth
公开号:US20040024009A1
公开(公告)日:2004-02-05
The present invention provides a compound of formula I and the use thereof for the immunotherapeutic treatment of transplant rejection, autoimmune disease or graft vs. host disease.
1